Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_assertion type Assertion NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_head.
- NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to asses]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_provenance.
- NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_assertion evidence source_evidence_literature NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_provenance.
- NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_assertion SIO_000772 12960109 NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_provenance.
- NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_assertion wasDerivedFrom gad-20150221 NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_provenance.
- NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_assertion wasGeneratedBy ECO_0000203 NP80676.RAvwP_hA6LsXSLK1yv6G1yANp9r8yFLfB5VrHUU6fdDiw130_provenance.